Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02954874 |
|---|---|
| Brief Title: | Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer |
| First Submitted : | November 3, 2016 |
| First Submitted that Met QC Criteria : | November 3, 2016 |
| First Posted : | November 4, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 12, 2020 |
| Last Update Posted : | February 13, 2020 |